Selecta Biosciences Inc. [NASDAQ:SELB] shares are showing an active tape with a current price of $1.93 on Thursday.
Selecta Biosciences Inc. is in the Healthcare sector under the Biotechnology industry. This week, we are watching the stock hit price per sales of 30.31 with an earning per share of -1.00.
For the year, the stock is trading -18.91% and the five-day change stands at 17.68%. As a point of reference, the S&P 500 is trading 0.79% YTD.
The Price is right
Holding a Market Cap of $203.06 million, Selecta Biosciences Inc. has seen a trading range over the last year of $1.28-$4.83.
For the last five days, SELB is up from its last closing price. The average shares trading hands each day is 1.60M.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for SELB. When we apply the Elder Force Index to Selecta Biosciences Inc., we are seeing an Elder Force Indicator number of 855808.15.
In the last quarter, SELB made a profit of 16.37 million. Selecta Biosciences Inc. also saw quarter revenue growth year over year of 639.42%.
Looking at popular technical indicators, the company’s 5-day moving average is 1.7180 compared to the 50-day moving average of 7.74%. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. SELB currently holds a 9-day RSI of 41.33%, while 100-day RSI stands at 46.68%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. SELB’s 9-day MACD is -0.2156 and the company’s 100-day MACD stands at -0.9953.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 17.36% by insiders and 60.21% by institutions. Regarding institutional holdings, BVF Inc. owns 7.74%, while the second top holder, Mangrove Partners, currently owns 6.11%.
Over the last six months, insiders have bought 530,441 with the most recent transaction from SPRINGER TIMOTHY A, Director, with a purchase at price 1.89 per share.
Overall, the recommended rating for SELB is Moderate Buy. Currently, the company has 7 analysts watching the stock, and the average quarterly earnings estimate is 0.1.